リソース

Partnering with patients to boost clinical research in rare diseases

Although much p… | Read More

詳しく読む
eCOA back-up strategies #whitepaper

No longer the “… | Read More

詳しく読む
Press Release // Kayentis raises €7M ($8.3M) to accelerate the global expansion of its digital platform for clinical trials

Funds will stre… | Read More

詳しく読む
eCOA set-up #whitepaper

How to anticipa… | Read More

詳しく読む
eCOA challenges of long term studies #whitepaper

How to anticipa… | Read More

詳しく読む
Kayentis Program for Carbon-Neutral Clinical Trials

“Through … | Read More

詳しく読む
Press Release // Kayentis launches new initiatives to bolster carbon-neutral clinical trials

Carbon-neutral … | Read More

詳しく読む
Make it simple: Use a single device! #infography

Discover the 3 … | Read More

詳しく読む
REGISTER FOR OUR VIRTUAL PRESENTATION – Nov 3, Clinical Trials Europe

eCOA SETUP: HOW… | Read More

詳しく読む
eCOA Training: how can we improve the sites’ and patients’ experience? #whitepaper

Focused on eCOA… | Read More

詳しく読む
Make clinical trials an enjoyable experience: use a small tablet device! #infography

A small tablet … | Read More

詳しく読む
2019 Employee Satisfaction Survey

Embrace our spi… | Read More

詳しく読む
eCOA in ophthalmology

There is an ext… | Read More

詳しく読む
Oncology Case Study: Global Phase III Oncology Study – Melanoma

With its strong… | Read More

詳しく読む
Put an end to eCOA misconceptions #infography

Discover below … | Read More

詳しく読む
eCOA training: How to maximize data collection and completeness?

Although tablet… | Read More

詳しく読む
Infography: Overcoming complexities in pediatric clinical studies

Approximately o… | Read More

詳しく読む
Key #5 for successful ePRO selection in your ophthalmology clinical trial: Anticipate cultural differences in multi country clinical trials

Before selectin… | Read More

詳しく読む
Kayentis supports the 1st personalized immunotherapy treatment approved by both FDA & EMA

Acute Lymphobla… | Read More

詳しく読む
ePRO and eDiary: What about using a single device?

With the increa… | Read More

詳しく読む
Infography: Emerging Biopharma & Biotech – Kayentis 5 keys for successful eCOA trials

Emerging Biopha… | Read More

詳しく読む
Patient Reported Outcomes: don’t skip that question!

When setting up… | Read More

詳しく読む
Press Release // Kayentis forges ahead on five new eCOA service projects with emerging biopharma firms in Europe and US

Kayentis sets u… | Read More

詳しく読む
3 reasons for using tablet for clinical data collection @Home

Electronic capt… | Read More

詳しく読む
Technological ways to make clinical trials really global

Although clinic… | Read More

詳しく読む
Overcoming the Complexities of Pediatric Clinical Trials

Although childr… | Read More

詳しく読む
Key #4 for successful ePRO selection in your ophthalmology clinical trial: Consider the method of ePRO administration

PROs in ophthal… | Read More

詳しく読む
Key #3 for successful ePRO selection in your ophthalmology clinical trial: Get your patients involved

Although clinic… | Read More

詳しく読む
Dermatology & autoimmune case study: an extensive eCOA experience in autoimmune, inflammatory and skin diseases

Kayentis has a … | Read More

詳しく読む
Key #2 for successful ePRO selection in your ophthalmology clinical trial: Use your PROs to power economic evaluations

Incorporating a… | Read More

詳しく読む
Misconception #5 on eCOA barriers: Regulatory bodies are reluctant to accept eCOA data

There seems to … | Read More

詳しく読む
Misconception #4 on eCOA barriers: Preparing for eCOA requires additional lead time

Time is of the … | Read More

詳しく読む
Key #1 for successful ePRO selection in your ophthalmology clinical trial: Ensure the ePRO answers the intended clinical endpoint

PROs have becom… | Read More

詳しく読む
Misconception #3 on eCOA barriers: eCOA implementation requires higher investment

A general misco… | Read More

詳しく読む
Misconception #2 on eCOA barriers: Data might be lost due to device failure

The fear of los… | Read More

詳しく読む
Misconception #1 on eCOA barriers: Patient training and re-training plan is a burden

As “end users “… | Read More

詳しく読む
Are barriers to eCOA adoption true hurdles?

Over recent yea… | Read More

詳しく読む
Switching to digital: why will it help clinical trials stakeholders?

The decline in … | Read More

詳しく読む
eCOA Back-up Solutions: Perception vs Reality

Digital solutio… | Read More

詳しく読む
Press Release // Kayentis opens Japanese subsidiary to support growth of Asia-Pacific clinical trials sector

Proximity will … | Read More

詳しく読む
How can digital innovation turn clinical trials into a positive patient and site experience?

Digital innovat… | Read More

詳しく読む
Kayentis gives back to its community by donating to two local associations

Aware of its re… | Read More

詳しく読む
Kayentis extends its contribution to scientific research in clinical trial endpoint assessment and joins the Critical Path Institute’s ePRO Consortium

Kayentis announ… | Read More

詳しく読む
eCOA study: Paper back-up and data reliability

eCOA study: the… | Read More

詳しく読む
Press Release // Kayentis appoints Estelle Haenel as medical director

25-year pharma … | Read More

詳しく読む
Inclusion and gender diversity is not a given!

This can only b… | Read More

詳しく読む
2018 Employee Satisfaction Survey

The results are… | Read More

詳しく読む
The benefits & practicalities of aligning the objectives of an eCOA vendor with those of the study

Any enduring bu… | Read More

詳しく読む
Including eCOA in a clinical trial in China

With a large pa… | Read More

詳しく読む
Six reasons to work at Kayentis

Here are 6 reas… | Read More

詳しく読む
Kayentis welcomes Estelle Haenel, PharmD, PhD, as Medical Director

Estelle Haenel … | Read More

詳しく読む
Waste Management Report 2018

Kayentis is com… | Read More

詳しく読む
Implementing Kayentis Spirit in the US, a key challenge for Kayentis team

Interview with … | Read More

詳しく読む
Challenges of back-up solutions in eCOA studies

Why is there a … | Read More

詳しく読む
Sustainable Mobility Report 2018

Moving together… | Read More

詳しく読む
Press release // OMRON Healthcare and Kayentis join forces to deliver an integrated and cost-efficient approach to remote monitoring of patients in clinical trials

We are proud to… | Read More

詳しく読む
Kayentis releases its 2018 customer satisfaction survey: The results are in!

Customer satisf… | Read More

詳しく読む
Kayentis & RWS Life Sciences Partnering for Success – Global Immunology & Dermatology Phase II Study

Kayentis & … | Read More

詳しく読む
Consolidation in the eCOA industry: How does this impact the quality of service delivery? and the choice of service providers?

The eCOA indust… | Read More

詳しく読む
Kayentis, a global expert in eCOA, is strenghening its US presence

Kayentis, exper… | Read More

詳しく読む
Kayentis Partners with OmniComm to Offer Integrated EDC and eCOA Solutions

    &… | Read More

詳しく読む
Infography: Employee Satisfaction Barometer 2017

Well-being at K… | Read More

詳しく読む
Kayentis announces the release of its new eCOA solution, Clin’form3 Suite

A multi-platfor… | Read More

詳しく読む
Infography: Kayentis added values for CROs

Kayentis is a g… | Read More

詳しく読む
Data Management Case Study

With a strong d… | Read More

詳しく読む
Dermatology case study: Global Phase III Studies – Psoriasis

After a case st… | Read More

詳しく読む
Mobile technologies & wearable devices for Healthcare and Clinical Research

Mobile technolo… | Read More

詳しく読む
// White paper // Digital Technology and Patients Tools in Clinical Trials – Part 2

Moving on from … | Read More

詳しく読む
Joining Kayentis: Values, mission and vision

Joining Kayenti… | Read More

詳しく読む
// White paper // Digital Technology and Patients Tools in Clinical Trials – Part 1

Digital technol… | Read More

詳しく読む
// White paper // The European Union General Data Protection Regulations

The European Un… | Read More

詳しく読む
// Innovation by Kayentis // R&D moves into an ‘Agile’ mode of operation

How the Agile m… | Read More

詳しく読む
What can eDiary bring to your study?

During a clinic… | Read More

詳しく読む
Accreditation by the French Ministry of Research

‘We are proud t… | Read More

詳しく読む
Infography: 7 lesser known advantages of eCOA over COA

Advantages of e… | Read More

詳しく読む
Cardiovascular case study: Global Phase III Study – Heart Failure & Actigraphy

After case stud… | Read More

詳しく読む
// White paper // Local storage or Cloud hosting?

Over the last 2… | Read More

詳しく読む
Actigraphy devices: a real impact on clinical research?

Actigraphy has … | Read More

詳しく読む
Advantages of direct review of patient-recorded data by clinicians

In ePRO clinica… | Read More

詳しく読む
//White paper// eCOA vs COA: pros and cons

Electronic tool… | Read More

詳しく読む
Hidden costs of paper ICFs

The past few ye… | Read More

詳しく読む
Infography: planning an oncology study with eCOA/ePRO

The FDA has pro… | Read More

詳しく読む
Improve your Risk-based Monitoring with eCOA solutions!

High-frequency … | Read More

詳しく読む
Data Management: a key factor in data quality

The constant in… | Read More

詳しく読む
Kayentis announces a breakthrough feature available in ePRO clinical trials: clinician review of data on a tablet device

It is essential… | Read More

詳しく読む
12 tips to succeed in your eCOA trial

You have chosen… | Read More

詳しく読む
eCOA solutions in oncology: What to consider when planning an oncology study with eCOA /ePRO?

The FDA has pro… | Read More

詳しく読む
#12 eCOA COMMITMENT: Kayentis is a real eCOA partner!

Because it&#821… | Read More

詳しく読む
//COAs white paper// Why are they important criteria in the evaluation of dossiers by health authorities?

Diverse element… | Read More

詳しく読む
#11 eCOA COMMITMENT: Kayentis has made its solutions fully and easily interoperable

Because it&#821… | Read More

詳しく読む
#10 eCOA COMMITMENT: What about using an eICF in your trial with Kayentis?

Because Kayenti… | Read More

詳しく読む
Kayentis goes one step further in the integration of electronic Informed Consent to improve patient convenience and sponsor efficiency

The announcemen… | Read More

詳しく読む
#9 eCOA COMMITMENT: Be cautious about clinical spend

Because clinica… | Read More

詳しく読む
Kayentis releases its 2016 customer satisfaction survey

Kayentis proud … | Read More

詳しく読む
#8 eCOA COMMITMENT: Kayentis makes monitoring more efficient and less costly

Because risk-ba… | Read More

詳しく読む
#7 eCOA COMMITMENT: For Kayentis, patient compliance is key for the success of your study

Because patient… | Read More

詳しく読む
#6 eCOA COMMITMENT: Kayentis delivers clean data in due course

Because raw dat… | Read More

詳しく読む
#5 eCOA COMMITMENT: Kayentis takes into account custom issues in its international studies

Because interna… | Read More

詳しく読む
#4 eCOA COMMITMENT: Kayentis ensures data transmission regardless of the country & site with the HIGHEST connectivity level

Because connect… | Read More

詳しく読む
#3 eCOA COMMITMENT: Kayentis has all you need to take care of YOUR DATA

Because your da… | Read More

詳しく読む
#2 eCOA COMMITMENT: Kayentis has solutions for ALL your eCOA needs

Because every s… | Read More

詳しく読む
#1 eCOA COMMITMENT: Kayentis is fully dedicated to eCOA

Because electro… | Read More

詳しく読む
Kayentis closes 3.6 M€ growth financing round

Innovation Capi… | Read More

詳しく読む
KAYENTIS announces its participation in the Avoca Diligent Prequalification Platform

Choosing a prov… | Read More

詳しく読む
How to handle connectivity issues in electronic Clinical Outcome Assessment (COA) clinical studies?

Connectivity is… | Read More

詳しく読む
Key benefits of using a “Tablet device” for eCOA in Psoriasis studies

Psoriasis is a … | Read More

詳しく読む
How to choose an electronic Clinical Outcome Assessment (eCOA) backup solution?

In recent years… | Read More

詳しく読む
The benefits of the eICF in patient engagement

The patient’s r… | Read More

詳しく読む
The 6 challenges to succeed in a global eCOA study

Several element… | Read More

詳しく読む
Infography to find out how to switch from COA to eCOA

Infography COA … | Read More

詳しく読む
Switching from COA to eCOA – 6 points checklist

Benefits genera… | Read More

詳しく読む
How complex authentication should be in eCOA devices?

Authentication … | Read More

詳しく読む
A step further in improving clinical trials: an electronic informed consent fully integrated into the eCOA solution

KAYENTIS signs … | Read More

詳しく読む
Kayentis signs up 5 new phase III clinical studies

These phase III… | Read More

詳しく読む
Kayentis announces the creation of its strategic committee

Four leading fi… | Read More

詳しく読む
Kayentis finalized its round of funding in february

Kayentis finali… | Read More

詳しく読む